In research exploring metabolic disorders (insulin resistance, obesity, fatty liver), one could use this peptide blend to test whether more physiologic GHpulsatility (via Ipamorelin) and sustained baseline elevation (via CJC-1295) better modulate glucose homeostasis, hepatic fat accumulation, or lipid oxidation compared to GH or GHRH alone
If you6re exploring a drainage-first plan, these resources can help: Why bile flow matters for detoxification How to support liver detox phases Can TUDCA cause detox symptoms
It is not for people on insulin therapy or people who experience problematic hypoglycemia
Diabetes Care 44(3):765773
Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats
True 98% purity, confirmed by validated HPLC and mass spectrometry, costs more to produce than loosely defined research grade material where peaks and impurities are neither fully identified nor consistently controlled